No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 53, Issue 7, 2012, Pages 1420-1422

  Mikeska, Thomas ^a,b   Carney, Dennis A ^a,b   Seymour, John F ^a,b   Dobrovic, Alexander ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BISULFITE; DNA POLYMERASE; GENOMIC DNA; PROTEIN P53;

BLOOD SAMPLING; BREAST CANCER; CANCER CELL CULTURE; CANCER STAGING; CELL DEATH; CELL STRAIN HCT116; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; CPG ISLAND; CYTOGENETICS; DNA DAMAGE; DNA METHYLATION; EXON; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GLIOMA CELL; HEAD AND NECK CANCER; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LETTER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RADIOSENSITIVITY; STOMACH LYMPHOMA;

ADULT; AGED; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; FEMALE; HCT116 CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84862735041     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.653640     Document Type: Letter

References (15)

1. Pleyer L, Egle A, Hartmann TN, et al. Molecular and cellular mechanisms of CLL: novel therapeutic approaches. Nat Rev Clin Oncol 2009;6:405-418.
2. Starostik P, Manshouri T, O'Brien S, et al. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia. Cancer Res 1998;58:4552-4557. (Pubitemid 28480612)
3. Pettitt AR, Sherrington PD, Stewart G, et al. p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 2001;98:814-822.
4. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-1916. (Pubitemid 32064784)
5. Ai L, Vo QN, Zuo C, et al. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev 2004;13:150-156. (Pubitemid 38116634)
6. Vo QN, Kim WJ, Cvitanovic L, et al. Th e ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene 2004;23:9432-9437. (Pubitemid 40069676)
7. Safar AM, Spencer H3, Su X, et al. un-methylated profiling of archived non-small cell lung cancer: a promising prognostic system. Clin Cancer Res 2005;11:4400-4405.
8. Huang Q, Su X, Ai L, et al. Promoter hypermethylation of multiple genes in gastric lymphoma. Leuk Lymphoma 2007;48:1988-1996. (Pubitemid 47542986)
9. Kim Wj, Vo QN, Shrivastav M, et al. Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 2002;21:3864-3871.
10. Roy K, Wang L, Makrigiorgos GM, et al. Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity. Biochem Biophys Res Commun 2006;344:821-826.
11. Brandes JC, Carraway H, Herman JG. Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter. Oncogene 2007;26:6229-6237. (Pubitemid 47414370)
12. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007;35:e41.
13. Mikeska T, Dobrovic A. Methylation-sensitive high resolution melting for the rapid analysis of DNA methylation. In: Craig JM, Wong NC, editors. Epigenetics: a reference manual. Norwich, UK: Caister Academic Press; 2011. pp 325-335.
14. Candiloro ILM, Mikeska T, Dobrovic A. Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation. Epigenetics 2011;6:500-507.
15. Martin-Guerrero I, Enjuanes A, Richter J, et al. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk. Genes Chromosomes Cancer 2011;50:887-895